Maragos WF - Search Results

1

Evidence that Par-4 participates in the pathogenesis of HIV encephalitis.

Kruman II, Nath A, Maragos WF, Chan SL, Jones M, Rangnekar VM, Jakel RJ, Mattson MP. Kruman II, et al. Among authors: maragos wf. Am J Pathol. 1999 Jul;155(1):39-46. doi: 10.1016/S0002-9440(10)65096-1. Am J Pathol. 1999. PMID: 10393834 Free PMC article.

2

Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum.

Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM. Bansal AK, et al. Brain Res. 2000 Oct 6;879(1-2):42-9. doi: 10.1016/s0006-8993(00)02725-6. Brain Res. 2000. PMID: 11011004

3

Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia.

Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M. Nath A, et al. J Psychopharmacol. 2000;14(3):222-7. doi: 10.1177/026988110001400305. J Psychopharmacol. 2000. PMID: 11106300 Review.

4

Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine.

Turchan J, Anderson C, Hauser KF, Sun Q, Zhang J, Liu Y, Wise PM, Kruman I, Maragos W, Mattson MP, Booze R, Nath A. Turchan J, et al. BMC Neurosci. 2001;2:3. doi: 10.1186/1471-2202-2-3. Epub 2001 Mar 2. BMC Neurosci. 2001. PMID: 11252157 Free PMC article.

5

Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat.

Maragos WF, Tillman P, Jones M, Bruce-Keller AJ, Roth S, Bell JE, Nath A. Maragos WF, et al. Neuroscience. 2003;117(1):43-53. doi: 10.1016/s0306-4522(02)00713-3. Neuroscience. 2003. PMID: 12605891

6

6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.

Maragos WF, Jakel RJ, Pang Z, Geddes JW. Maragos WF, et al. Exp Neurol. 1998 Dec;154(2):637-44. doi: 10.1006/exnr.1998.6918. Exp Neurol. 1998. PMID: 9878198

7

Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions.

Maragos WF, Tillman PA, Chesnut MD, Jakel RJ. Maragos WF, et al. Brain Res. 1999 Jul 10;834(1-2):168-72. doi: 10.1016/s0006-8993(99)01487-0. Brain Res. 1999. PMID: 10407109

8

Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M. Flora G, et al. Exp Neurol. 2003 Jan;179(1):60-70. doi: 10.1006/exnr.2002.8048. Exp Neurol. 2003. PMID: 12504868

9

Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction.

Theodore S, Cass WA, Nath A, Steiner J, Young K, Maragos WF. Theodore S, et al. Among authors: maragos wf. Neurobiol Dis. 2006 Sep;23(3):663-8. doi: 10.1016/j.nbd.2006.05.005. Epub 2006 Jul 7. Neurobiol Dis. 2006. PMID: 16828290

10

Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.

Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA. Maragos WF, et al. J Neurochem. 2002 Nov;83(4):955-63. doi: 10.1046/j.1471-4159.2002.01212.x. J Neurochem. 2002. PMID: 12421368 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters